{"doi":"10.1128/aac.02183-19","title":"Carbapenem-Resistant Gram-Negative Bacterial Infections in Children","abstract":"<jats:p>\n            Carbapenem-resistant organisms (CRO) are a major global public health threat.\n            <jats:italic>Enterobacterales</jats:italic>\n            hydrolyze almost all β-lactams through carbapenemase production. Infections caused by CRO are challenging to treat due to the limited number of antimicrobial options. This leads to significant morbidity and mortality. Over the last few years, several new antibiotics effective against CRO have been approved.\n          </jats:p>","journal":"Antimicrobial Agents and Chemotherapy","year":2020,"id":637195,"datarank":0.6846522287201755,"base_score":4.564348191467836,"endowment":4.564348191467836,"self_citation_contribution":0.6846522287201755,"citation_network_contribution":0.0,"self_endowment_contribution":0.6846522287201755,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":95,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1654313,"name":"Luis Escosa-García","orcid":null,"position":1,"is_corresponding":false},{"id":1654314,"name":"Jesús Saavedra-Lozano","orcid":null,"position":2,"is_corresponding":false},{"id":1641353,"name":"Emilia Cercenado","orcid":null,"position":3,"is_corresponding":false},{"id":178541,"name":"Fernando Baquero-Artigao","orcid":null,"position":4,"is_corresponding":false},{"id":1654311,"name":"David Aguilera-Alonso","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Carbapenem-Resistant Gram-Negative Bacterial Infections in Children","abstract":"<jats:p>\n            Carbapenem-resistant organisms (CRO) are a major global public health threat.\n            <jats:italic>Enterobacterales</jats:italic>\n            hydrolyze almost all β-lactams through carbapenemase production. Infections caused by CRO are challenging to treat due to the limited number of antimicrobial options. This leads to significant morbidity and mortality. Over the last few years, several new antibiotics effective against CRO have been approved.\n          </jats:p>","is_dataset_classified":null,"base_score":4.564348191467836,"endowment":4.564348191467836,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"31844014","pmcid":null,"openalex_id":"https://openalex.org/W2995636661","authors":[],"funders":[{"funder_name":"MEC | Instituto de Salud Carlos III","grant_id":"CM18/00100","title":null}],"total_grants":1,"fwci":2.2602,"citation_percentile":0.89573571,"influential_citations":0,"citation_trend":[{"year":2018,"count":2},{"year":2020,"count":8},{"year":2021,"count":13},{"year":2022,"count":12},{"year":2023,"count":14},{"year":2024,"count":28},{"year":2025,"count":11},{"year":2026,"count":7}],"oa_status":"green","license":"https://journals.asm.org/non-commercial-tdm-license","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7038253","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7038253","host_type":"repository"},{"url":"https://journals.asm.org/doi/pdf/10.1128/AAC.02183-19","host_type":"publisher"},{"url":"https://doi.org/10.1128/aac.02183-19","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/31844014","host_type":"repository"}],"fields_of_study":["Antibiotic Resistance in Bacteria","Antibiotics Pharmacokinetics and Efficacy","Antibiotic Use and Resistance"],"mesh_terms":["Anti-Bacterial Agents","Ceftazidime","Drug Combinations","Humans","Carbapenems","Gram-Negative Bacterial Infections","Drug Resistance, Multiple, Bacterial","Azabicyclo Compounds","beta-Lactamase Inhibitors"],"keywords":["Carbapenem","Antibiotics","Antimicrobial","Gram-negative bacterial infections","Gram","Microbiology","Medicine","Gram-negative bacteria","Biology","Intensive care medicine","Bacteria","Escherichia coli"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T18:29:56.082797Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}